Contact Us

In addition to assembling a diversified team with expertise in each area of branding, investor relations, public relations and social media, we have developed a network of brands and partners to best serve both public and private companies. By engaging any one of our services, you will benefit from decades of experience accumulated by helping more than 250 companies achieve greater success.

Contact Us

    Your Name *

    Your Email *

    Subject

    Message:

    Get Your Copy of The StocksToBuyNow Newsletter

    You’re just a click and email verification away from joining hundreds of other subscribers receiving weekly trading ideas!

    From Our Blog

    Lixte Biotech Holdings Inc. (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expands Clinical and Strategic Partnerships

    April 9, 2026

    Lixte Biotechnology (NASDAQ: LIXT) is emerging as a differentiated player in the oncology ecosystem, advancing a precision-driven approach to cancer treatment which focuses on improving the effectiveness of existing. As a clinical-stage pharmaceutical company, the company is advancing novel compounds built around a unique biological target, with its lead candidate, LB-100, at the nucleus of […]

    Rotate your device 90° to view site.